Persistent Chlamydia Pneumoniae serology is related to decline in lung function in women but not in men. Effect of persistent Chlamydia pneumoniae infection on lung function
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationBMC Pulm Med. 2010, 10:44
AbstractBACKGROUND: Chlamydia pneumoniae (C pn) infection causes an acute inflammation in the respiratory system that may become persistent, but little is known about the long-term respiratory effects of C pn infections. Aim: To estimate the long term respiratory effects of C pn with change in forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) as a main outcome variable. METHODS: The study comprised of 1109 subjects (500 men and 609 women, mean age 28 ± 6 years) that participated in the Reykjavik Heart Study of the Young. Spirometry and blood samples for measurements of IgG antibodies for C pn were done at inclusion and at the end of the follow-up period (mean follow-up time 27 ± 4 years). RESULTS: Having IgG against C pn at both examinations was significantly associated to a larger decrease in FEV1 (6 mL/year) and FVC (7 mL/year) in women but not in men. In women the association between C pn and larger FEV1 decline was only found in women that smoked at baseline where having C pn IgG was associated with 10 mL/year decline compared to smokers without C pn IgG. These results were still significant after adjustment for age, smoking and change in body weight. CONCLUSION: Our results indicate that persistent C pn serology is related to increased decline in lung function in women but not in men. This effect was, however, primarily found in smoking women. This study is a further indication that the pathophysiological process leading to lung impairment may differ between men and women.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Chlamydia pneumoniae serology, lung function decline, and treatment for respiratory disease.
- Authors: Strachan DP, Carrington D, Mendall M, Butland BK, Yarnell JW, Elwood P
- Issue date: 2000 Feb
- Acute Chlamydia pneumoniae infections in asthmatic and non-asthmatic military conscripts during a non-epidemic period.
- Authors: Juvonen R, Bloigu A, Paldanius M, Peitso A, Silvennoinen-Kassinen S, Harju T, Leinonen M, Saikku P
- Issue date: 2008 Mar
- CRP is associated with lung function decline in men but not women: a prospective study.
- Authors: Ólafsdóttir IS, Gíslason T, Gudnason V, Benediktsdóttir B, Ólafsson Í, Aspelund T, Thjódleifsson B, Janson C
- Issue date: 2013 Jan
- Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD.
- Authors: Brandén E, Koyi H, Gnarpe J, Gnarpe H, Tornling G
- Issue date: 2005 Jan
- Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection.
- Authors: Cosentini R, Tarsia P, Canetta C, Graziadei G, Brambilla AM, Aliberti S, Pappalettera M, Tantardini F, Blasi F
- Issue date: 2008 May 30